John Nycz, co-founder and CEO of Rapha Digital Health, joins the show to talk about fixing one of healthcare's most overlooked gaps — fibromyalgia diagnosis and treatment. In this episode, John shares how a near-fatal car accident sparked his path into alternative medicine, and how a career in Lean Six Sigma led him to build a telehealth ecosystem designed to get patients answers in 90 days instead of seven years.

#DigitalHealth #Telehealth #Fibromyalgia #ChronicIllness #HealthcareInnovation #PrecisionMedicine #HealthTech #ZeroFrictionPodcast #RaphaDigitalHealth #JohnNycz

AI is already changing healthcare. 🤖🏥

Dr. Jason Jones shares how AI-powered ambient documentation is saving physicians hours each week, reducing administrative burden, and helping doctors focus more on patient care.

Watch the full Zero Friction episode with Dr. Jason Jones for insights on AI, orthopedic care, concierge medicine, and the future of healthcare.

#AI #HealthcareAI #Orthopedics #PatientCare #ZeroFriction #RevRxAI #JasonJones

In this episode, Terry sits down with Tad Hartlaub — Managing Director and Co-Founder of MedVance Marketing — to unpack the realities of launching and scaling MedTech startups in today’s healthcare landscape. With more than 20 years in medical device marketing, 30+ product launches, and multiple medical device patents, Tad shares what it really takes to move innovation from idea to clinical adoption.

From university incubators and startup funding challenges to hospital procurement barriers and market-fit strategy, this conversation dives into the friction points that can make or break healthcare innovation.

Episode at a glance:

-How MedVance helps MedTech and biotech startups bridge the gap between innovation and clinical adoption
-Why market-fit analysis is critical before FDA approval and commercialization
-The hidden friction points inside hospital systems, value analysis committees, and healthcare purchasing
-How startups can better communicate clinical and economic value to healthcare stakeholders
-The role of KOLs, clinical champions, and strategic messaging in accelerating adoption
-Tad’s journey from product patents and Fortune 500 healthcare companies to launching MedVance Marketing
-Advice to founders and innovators: keep your head in the clouds while keeping your feet on the ground

MedVance Marketing Website: https://www.medvancemarketing.com
Connect with Tad Hartlaub on LinkedIn:   / tad-hartlaub-5b4014a5  

A 40-second eye exam could transform the future of eye care. 👁️

On this episode of Zero Friction, Terry sits down with Stan Miele to explore how advanced imaging technology and precision medicine are changing the way clinicians diagnose and treat eye conditions.

From real-time ocular surface imaging to the future of personalized eye care, this conversation dives into the innovation shaping the next generation of ophthalmology and medtech.

#ZeroFriction #RevRxAI #ADOM #TearFilmImager #OcularSurfaceDisease #DryEye #EyeCareInnovation #MedTech #Biotech #PrecisionMedicine #Entrepreneurship #AIandInnovation #StanMiele #ADOM #AdvancedOpticalTechnologies

What if AI and precision medicine could transform the future of heart failure treatment?

On this episode of Zero Friction, Terry sits down with Ayla Annac, co-founder and CEO of Invivo Sciences, to explore how AI-driven biotechnology and patient-specific heart tissue models are reshaping cardiac care and the future of precision medicine.

#ZeroFriction #RevRxAI #HeartFailure #PrecisionMedicine #AIHealthcare #Biotech #Cardiology #ZeroFrictionPodcast #AlyaAnnac #InvivoSciencesInc #InvivoSciences

The conversation covers the introduction and background of Delphistem, the journey of Danae and Dr. Noel Moya, the vision and challenges of Delphistem, the current standard of care for diabetes, the financial aspects of entrepreneurship, the path forward and fundraising for clinical trials, and advice to younger selves. The key takeaways include the groundbreaking stem cell technology and the impactful mission of Delphistem.

Takeaways

• Groundbreaking Stem Cell Technology
• Impactful Mission

Chapters

• 00:00 Advice to Younger Selves

Nathan J. Castro, co-founder and CTO of Nanacon, shares the innovative work his company is doing in the orthopedic space, focusing on knee cartilage repair.

He discusses the development of a paradigm-shifting approach using 3D printing technology to create mechanically robust implants, providing a solution for patients with cartilage injuries.

The company is currently in the process of safety studies and regulatory approval, with a projected market entry in 2029.

Takeaways

• Orthopedic Innovation
• 3D Printing for Cartilage Repair

Chapters

• 00:00 Introduction to Nanacon and Orthopedic Innovation
• 19:00 Early Research and Development Work
• 25:32 Revolutionary Technology for Cartilage Repair
• 31:29 Path to Market and Regulatory Approval
• 40:11 Life Advice and Closing Remarks

30% of your workforce may be neurodivergent.

Most companies have no idea how to support them.

On the latest Zero Friction, I sat down with Keeley Shoup, CEO of Cuddlist, Inc. — and what started as a conversation about consent-based connection quickly became one of the most important discussions I've had about the neurodivergent workforce.

Here's what stopped me cold:

A significant and growing percentage of your team may be neurodivergent. And most workplace environments — the way we communicate, collaborate, and connect — were never designed with them in mind.

That's not a culture problem. That's a performance problem.

Keeley is doing the hard work of helping organizations understand what true inclusion actually requires — beyond the policy, beyond the training, beyond the checkbox.

If you lead people, this conversation is for you.

🎙️ Zero Friction — Removing Barriers from Revenue Growth 🔗 [Link in comments]

#ZeroFriction #NeurodivergentWorkforce #WorkplaceInclusion #Leadership #PsychologicalSafety #RevRxAI

Nathalya Mamane, co-founder and CEO of Anywhere DX, shares her journey of transitioning from event planning to the diagnostic world and the mission to democratize diagnostics access. She identifies personal pain points and develops a consumer-based lab-grade test at an affordable cost. Challenges in the diagnostic industry, lessons learned, and the vision of success for Anywhere DX are also discussed.

Takeaways

• Democratizing diagnostics access
• Challenges in finding capital for diagnostic solutions

Chapters

• 00:00 Democratizing Diagnostics Access
• 08:39 From Concept to Company
• 16:26 Mission of Anywhere DX
• 27:56 Excitement and Crowdfunding